Para-aortic Lymph Node Study for Pancreatic Cancer
Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer
Recruiting
N/A
Interventional Study
Pancreas Cancer
Pancreas Adenocarcinoma
Lymph Node Metastasis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 300 (estimated)
- Sponsor
- Jon Unosson · Other
Who this trial is looking for
This trial is looking for patients with resectable or borderline resectable pancreatic cancer who might need surgery. Participants will have their para-aortic lymph nodes removed to understand how often cancer spreads to these nodes and what that means for their treatment outcomes.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with resectable or borderline resectable pancreatic cancer
- I need a type of surgery called duodenopancreatectomy
- I am over 18 years old
- I can provide written consent to participate
You may not be able to join if
- I cannot have a radical resection procedure
- I have an unresectable tumor or metastatic disease
- I have mental or organic disorders that affect my ability to give consent or receive treatment
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Lymph node metastases are a strong prognostic predictor for pancreatic cancer. Para-aortic lymph nodes (PALN) are the final nodes for periampullary cancers before the cancer cells enter the systemic lymphatic circulation. Some consider these nodes to be regional lymph nodes and dissect them as a part of a routine lymphadenectomy for pancreatic cancer. Others argue that metastases to these nodes re…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Resectable suspected periampullary cancer (requiring duodenopancreatectomy) (NCCN guidelines 2020)
Borderline resectable periampullary cancer (requiring duodenopancreatectomy) (NCCN guidelines 2020)
Age \>18 years
Written patient consent
Exclusion Criteria:
Contraindication…
Contacts